Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.50 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.50 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.50 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.50 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9177111 | 0.98 | TSHR (0.57) | TSHRTP53ALDH1A1SMN1; SMN2SRD5A2 | |
| Methyl Alcohol SCHEMBL27778102 | 0.98 | TSHR (0.57) | TSHRTP53ALDH1A1SMN1; SMN2SRD5A2 | |
| Hydrochloric Acid SCHEMBL7347939 | 0.98 | TSHR (0.57) | TSHRTP53ALDH1A1SMN1; SMN2SRD5A2 | |
| SCHEMBL28556830 | 0.95 | ALDH1A1 (0.56) | TSHRTP53ALDH1A1SMN1; SMN2SRD5A2 | |
| Ethylene Glycol SCHEMBL7042192 | 0.91 | TP53 (0.50) | TSHRTP53ALDH1A1SMN1; SMN2SRD5A2 | |
| Oxirane SCHEMBL27918303 | 0.89 | TP53 (0.48) | TSHRTP53ALDH1A1SMN1; SMN2SRD5A2 | |
| Trifluoroacetic Acid SCHEMBL21177989 | 0.88 | EPHX2 (0.46) | TSHRTP53ALDH1A1SMN1; SMN2SRD5A2 | |
| Acedoben SCHEMBL8346780 | 0.88 | ALDH1A1 (0.59) | TSHRTP53ALDH1A1SMN1; SMN2CA1 | |
| SCHEMBL11747257 | 0.86 | HCAR3 (0.49) | TSHRTP53ALDH1A1SMN1; SMN2CA1 | |
| Tetrylammonium SCHEMBL11746115 | 0.86 | ALDH1A1 (0.47) | TSHRTP53ALDH1A1SMN1; SMN2SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119472-B | Negative photosensitive polyimide resin, preparation method thereof, photoresist composition and application | 华东理工大学 | 2026-02-27 | — | — | CN | claimed |
| EP-4612137-A1 | CROWN ETHER AMINES AND METHODS OF USE | Pall Corporation (US) | 2025-09-10 | — | — | EP | claimed |
| US-20250276974-A1 | PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM | OLON S.P.A. (IT) | 2025-09-04 | — | — | US | claimed |
| CN-120060858-A | Multi-position integrated intelligent corrosion inhibitor and preparation method and application thereof | 中国科学院海洋研究所 | 2025-05-30 | — | — | CN | claimed |
| CN-119660979-A | Water treatment agent for oilfield reinjection water and preparation method thereof | 郑州德融科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4522619-A1 | PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM | OLON S.p.A. (IT) | 2025-03-19 | — | — | EP | claimed |
| CN-119411256-A | Recycled colored polyester bulked filament prepared by grading shading and coloring technology | 江苏凯普特新材料科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119119472-A | Negative photosensitive polyimide resin, preparation method thereof, photoresist composition and application | 华东理工大学 | 2024-12-13 | — | — | CN | claimed |
| WO-2024110862-A9 | PROCESS FOR PREPARING ZANUBRUTINIB | OLON S.P.A. (IT) | 2024-11-28 | — | — | WO | claimed |
| WO-2024110862-A1 | PROCESS FOR PREPARING ZANUBRUTINIB | OLON S.P.A. (IT) | 2024-05-30 | — | — | WO | claimed |
| EP-0623635-B1 | Amine-functionalized polyester | GEN ELECTRIC (US) | 2003-02-19 | — | — | EP | claimed |
| WO-2002095393-A2 | DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2002-11-28 | — | — | WO | claimed |
| EP-0144329-B1 | PROTECTIVE COATING PROCESS FOR ALUMINUM AND ALUMINUM ALLOYS | Lockheed Corporation (US) | 1989-12-06 | — | — | EP | claimed |
| EP-0078642-B1 | RADIOPHARMACEUTICAL COMPOSITION BASED ON TECHNETIUM-99M AND REAGENT FOR MAKING IT | AMERSHAM INTERNATIONAL plc (GB) | 1986-12-10 | — | — | EP | claimed |
| EP-0144329-A1 | PROTECTIVE COATING PROCESS FOR ALUMINUM AND ALUMINUM ALLOYS. | LOCKHEED CORP (US) | 1985-06-19 | — | — | EP | claimed |
| US-4520052-A | IMMERSION IN ALKALINE SOLUTION CONTAINING A CUPRIC SALT, A COMPLEXING AGENT AND A REDUCING AGENT | TELEFONAKTIEBOLAGET L M ERICSSON (SE) | 1985-05-28 | — | — | US | claimed |
| WO-1984004549-A1 | PROTECTIVE COATING COMPOSITION AND PROCESS FOR ALUMINUM AND ALUMINUM ALLOYS | LOCKHEED CORP (US) | 1984-11-22 | — | — | WO | claimed |
| US-4451451-A | Radiopharmaceutical composition based on technetium-99m and reagent for making it | AMERSHAM INTERNATIONAL PLC (GB) | 1984-05-29 | — | — | US | claimed |
| EP-0078642-A2 | Radiopharmaceutical composition based on technetium-99m and reagent for making it | AMERSHAM INTERNATIONAL plc (GB) | 1983-05-11 | — | — | EP | claimed |
| US-4211883-A | Process for the production of p-(N-methyl)-aminobenzoyl-L-glutamic acid | LONZA, LTD. (CH) | 1980-07-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250276974-A1 | PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM | ZYX, ABL2, FYN | TSHR 3731/4885TP53 842/4885ALDH1A1 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.